CN Patent

CN119698414A — 一种吲哚-苯基哌啶化合物及其制备方法与应用

Assigned to Shenzhen Salubris Pharmaceuticals Co Ltd · Expires 2025-03-25 · 1y expired

What this patent protects

本申请属于化学药物技术领域，涉及一种通式(I)所示的化合物，或其消旋体、或其异构体、或其可药用的盐，作为一种补体B因子抑制剂以及使用其治疗多种特定疾病或病状的方法。

USPTO Abstract

本申请属于化学药物技术领域，涉及一种通式(I)所示的化合物，或其消旋体、或其异构体、或其可药用的盐，作为一种补体B因子抑制剂以及使用其治疗多种特定疾病或病状的方法。

Drugs covered by this patent

iptacopan-hydrochloride (IPTACOPAN HYDROCHLORIDE)

Patent Metadata

Patent number: CN119698414A
Jurisdiction: CN
Classification: —
Expires: 2025-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen Salubris Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.